Skip to main content
Journal of Community Genetics logoLink to Journal of Community Genetics
. 2025 May 15;16(3):243–254. doi: 10.1007/s12687-025-00801-7

Lack of provision of social and emotional information about Down syndrome associated with negative prenatal diagnosis experiences

Stephanie Meredith 1,, Harold L Kleinert 2, Jian Li 3, Sierra Weiss 2, Jonathan Drummond 2
PMCID: PMC12202255  PMID: 40372673

Abstract

To determine how physician adherence to recommended practices for discussing Down syndrome (DS) impacts patient experiences, and which of these recommendations most correlate with positive prenatal patient experiences. Online surveys were distributed to mothers of children with DS born between 2016–2021. The descriptions of prenatal experiences were assigned sentiment analysis scores: positive, negative, or neutral. The scores were then compared against the adherence of clinicians to recommended practices for delivering prenatal screening results. Of the 167 patients in this study, over 50% described a negative experience. The odds of having a neutral/positive diagnosis experience were about 18 times greater for those patients whose physicians adhered to all seven social recommendations. The odds of having a positive/neutral screening experience were 11.4 times greater for those patients whose physicians adhered to both emotional recommendations (not saying “I’m sorry” or conveying the diagnosis as bad news”). Most of the variance in the patient diagnosis experience was attributed to adherence to emotional recommendations and social recommendations. To meet the needs of patients, obstetricians need to address emotional, social, and informational needs by providing 1) access to balanced and accurate information about disabilities and 2) being better trained on sensitive communications.

Supplementary Information

The online version contains supplementary material available at 10.1007/s12687-025-00801-7.

Keywords: Down syndrome, Prenatal screening, Cell-free DNA screening, Trisomy 21, Prenatal diagnosis, Disability, Obstetrician, Genetic counselor

Introduction

For over 20 years, researchers in both the United States and Europe have repeatedly highlighted the negative experiences of parents when medical professionals deliver the news about a prenatal diagnosis of Down syndrome (DS) (Artal et al. 2024; Hedov et al. 2002; May et al. 2020; Meredith et al. 2023; Nelson Goff et al. 2013; Skotko 2005; Williams et al. 2002). Research by Nelson Goff et al. about the initial DS Diagnosis experience showed that among parents who received a prenatal diagnosis of DS, negative experiences with medical professionals were three times more likely than positive experiences (2013). Research exploring the psychological impact of a DS diagnosis by May et al. shows that these negative experiences can lead to lasting emotional harm given that diagnosis experiences qualify as flashbulb memories that parents remember lucidly for decades (2020). Moreover, negative diagnosis experiences can harm relationships between providers and the parents of medically vulnerable children with DS, particularly Hispanic parents of children with DS (Chung et al. 2023).

Multiple studies also point to the same causes for negative diagnosis experiences: the perception of pressure about pregnancy decisions, specifically bias toward terminating the pregnancy; the perpetuation of negative stereotypes about DS; perceived lack of sensitivity and compassion; and the lack of provision of information about DS (Artal et al. 2024; May et al. 2020; Meredith et al. 2023; Nelson Goff et al. 2013; Skotko 2005). Parents have repeatedly indicated that they want information that covers medical issues, life outcomes, local and national DS organization contact information, and supports and services that are particularly important as social determinants of health for people with disabilities at the first point on the life course (Hippman et al. 2012; May et al. 2020; Meredith et al. 2023; Sheets et al. 2011a, b).

Most obstetric care providers do not receive training about how to discuss DS (or other disabilities) when delivering a prenatal screening results, and bias can impact their provision of information (Driscoll et al. 2009; Meredith et al. 2023), some guidance from researchers and national obstetric and genetic organizations is available to help clinicians navigate those complex conversations (American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics et al. 2020; Bull et al. 2022; Sheets et al. 2011a, b; Skotko et al. 2009). Following a literature review by the Down Syndrome Diagnosis Study Group led by Dr. Brian Skotko, Down syndrome medical experts recommend that clinicians provide accurate, balanced, and up-to-date information about the condition and contact information for parent support groups (Skotko et al. 2009) and also center individual counseling on the personal values and preferences of the patient (Crombag et al. 2020). Additionally, recommendations published by the American College of Obstetricians and Gynecologists (ACOG) (American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics et al. 2020), the National Society of Genetic Counselors (NSGC) (Sheets et al. 2011a, b), the American Academy of Pediatrics (AAP) (Bull et al. 2022), the American College of Medical Genetics and Genomics (ACMG) (Gregg et al. 2016), and the International Society for Prenatal Diagnosis (ISPD) (Hui et al. 2023) add that the information about DS should cover medical care, developmental and educational information, supports and services, and psychosocial life outcomes.

However, research has yet to quantify the impact of obstetrician adherence to recommended practices on patient diagnosis experiences or the most significant types of information during those first conversations about DS. The present study investigated the extent to which adherence to the recommended practices impacts patients'self-described diagnosis experiences by assessing the data to answer these two research questions:

  1. How does physician adherence to the recommended practices impact patient diagnosis experiences?

  2. Which of the three adherence predictors examined in this study (e.g., medical, social, and emotionally oriented recommendations) is relatively more important than the others in accounting for patient diagnosis experiences?

Methods

The present study is an analysis of an unpublished portion of the data set originally collected by the authors which included parents of children with DS born between 2016 and 2021 (Ijaz et al. 2024; Meredith et al. 2023). Eligible participants were 18 years or older, US residents, and either received screening results suggesting a likely DS diagnosis or received a confirmed result via diagnostic testing. Online surveys were shared with members of the national Down Syndrome Diagnosis Network (DSDN) and 12 local DS organizations reflecting a cross-section of rural, suburban, and urban areas (see Table 1) (Ijaz et al. 2024; Meredith et al. 2023).

Table 1.

Local Down Syndrome Organization Study Partners5,18

Local DS Organizations State Type
Montgomery County Down Syndrome Interest Group PA Suburban
Down Syndrome Association of Central NJ NJ Suburban
Green River Area Down Syndrome Association KY Rural
Down Syndrome Association of Houston TX Urban and suburban
Down Syndrome Association of Greater Cincinnati OH Urban and suburban
Down Syndrome Association of Middle Tennessee TN Urban and suburban
21 Connect NY Urban and suburban
Down Syndrome Connection of the Bay Area CA Urban and suburban
Down Syndrome Connection of Northwest Arkansas AR Suburban and rural
Down Syndrome Association of Brevard FL Suburban and rural
Down Syndrome Connections of the Northwest ID Rural
Down Syndrome Network of West Virginia WV State-wide

As reported in Table 2 (demographic data) and Table 3 (CHERRIES Checklist) (Ijaz et al. 2024; Meredith et al. 2023), the survey included demographic questions, background clinical information, qualitative questions about prenatal diagnosis experiences, and 14 yes/no quantitative questions about whether obstetricians (OBs) followed recommended practices for delivering a suspected or confirmed diagnosis. (See Table 4.) The study was approved for human subjects research by the University of Kentucky IRB (55,360), and participants completed IRB-approved online consent forms.

Table 2.

Demographical and clinical background of participants

Variable Total Sample (n = 167) % Occurrence
Year of Diagnosis
  2016 8 4.8%
  2017 19 11.4%
  2018 21 12.6%
  2019 32 19.1%
  2020 65 38.9%
  2021 20 12.0%
 Unspecified 2 1.2%
Ethnicity*
  Hispanic or Latino or Spanish Origin 18 10.7%
  Not Hispanic or Latino or Spanish Origin 127 76.0%
  Unspecified 22 13.2%
Race*
  American Indian or Alaska Native 1 0.5%
  Asian 1 0.5%
  Black or African American 4 2.1%
  Native Hawaiian or Other Pacific Islander 1 0.5%
  White 127 82.0%
  Unspecified 22 13.2%
Clinicians Providing Treatment**
  Obstetrician/Gynecologist 163 97.6%
  Maternal Fetal Medicine Specialist 148 88.6%
  Genetic Counselor 104 62.3%
  Geneticist 30 18.0%
Types of Test**
  Cell-free DNA test or non-invasive prenatal screening 118 71.0%
  Traditional maternal-serum screening (like the quad screen) 45 26.9%
  Ultrasound 103 61.7%
  Chorionic villus sampling (CVS) 10 6.0%
  Amniocentesis 49 29.3%
Study Referrals
  DSDN 110 65.9%
  Local DS Org 53 31.7%
  Unspecified 4 2.4%
At what stage(s) do you think it's most critical for medical professionals to give accurate, balanced information about Down syndrome or other genetic conditions? **
Prior to screening 31.1%
  After screening 88.0%
  After diagnostic testing 52.1%
What types of informational resources about conditions do patients prefer?**
  Printed 113 67.7%
  Online 106 63.5%
  Other: Peer mentor, local organization, online support group 41 24.6%
Composite Sentiment Score (n = 167)
  Negative 85 50.9%
  Neutral 31 18.6%
  Positive 51 30.5%
OB Sentiment Score (n = 98)
  Negative 53 54.1%
  Neutral 36 36.7%
  Positive 9 9.2%
MFM Sentiment Score (n = 54)
  Negative 28 51.9%
  Neutral 21 38.9%
  Positive 5 9.3%

* The questions about where respondents learned about the survey, state of residence, and race were not added to the survey until 1/27/21

** Participants could select multiple options

Table 3.

Checklist for reporting results of internet E-surveys (CHERRIES)5,18

Design Target population Parents of children with DS born between January 1, 2016 and December 31, 2021
Sample frame Parents of children with DS referred by the Down Syndrome Diagnosis Network or 12 local DS Organizations (Table 1)
Type of sample Convenience sample
IRB IRB Approval Consent was received
Informed Consent

Potential survey participants were provided information about length of time of the survey, which data were stored and how data would be used, who the investigator was, and the purpose of the study. They were then asked to confirm whether or not they wanted to participate

See Appendix B

Data protection Collected data in university password-protected Qualtrics online database
Development and pre-testing Development and testing The test was reviewed prior to distribution by representatives of 12 local organizations and 3 internal university staff. Usability and technical functionality also assessed with Qualtrics internal tool
Recruitment process and description of the sample having access to the questionnaire Open survey versus closed survey Limited access survey: custom link only shared with invited participants via email or private or semi-private social media parent groups
Contact Mode Shared via private and semi-private advocacy organization social media groups and emails from local advocacy organization directly to new parents. Social media and emails shared quarterly. Search engines were blocked from indexing the survey
Advertising the survey Advertising in private and semi-private advocacy organization social media groups. See Appendix B
Survey Administration Web/E-mail E-survey not posted on a website. Shared via private and semi-private advocacy organization social media groups and emails to potential participants
Context DSDN shared survey invitations on private Facebook groups divided by birth year. The local organizations sent emails to parents of children 5 and under and shared on semi-private organizational social media pages
Mandatory/Voluntary Voluntary
Incentives No incentives
Time/Date

Local organizations: 4/29/2020–12/31/2021

DSDN: 1/27/2021–12/31/2021

Randomization of items or questionnaires No randomization used
Adaptive questioning Adaptive questions appeared depending on the types of providers seen by patients
Number of items 17 (2 of the 17 questions had 16 sub-items for a total of 47 items)
Number of screens (pages) 3
Completeness check Checked for completeness after questionnaire was submitted. Completion determined by whether patient completed Question 8 or 9
Review step Questions 8–17 appear on page 3 which allows for scrolling to change answers
Response Rate Unique site visitor Each user was identified with cookies
View rate Because the survey did not have a link tracked on a website, view rates are not available
Participation rate 99.8% of participants agreed to complete the survey 423/424. 25 participants were ineligible (7 received a postnatal diagnosis, 9 were outside the US, and 9 were outside the study time frame for a prenatal diagnosis)
Completion rate 61% of the eligible participants completed the survey 243/399
Preventing multiple entries from the same individual Cookies used and IP Check Cookies and duplicate IP addresses were used to prevent multiple responses. Selected Qualtrics setting to prevent respondents from taking the survey multiple times
Registration No registration required
Analysis Handling of Incomplete Questions Surveys were included as long as they completed at least through question 8 and/or 9

Table 4.

Frequencies and Pearson Chi-square tests for guideline adherence indicators (N = 167)

Variable Category Negative Neutral/Positive χ2 df p-value Cramer's V
N % N % Total N
Medical Guideline
My doctor set up a phone or face-to-face appointment to share the prenatal screening/test results with me so that I could process the information Disagree 42 61.8% 26 38.2% 68 6.23 1 0.013 0.20
Agree 38 41.8% 53 58.2% 91
My doctor presented me with all pregnancy options Disagree 24 61.5% 15 38.5% 39 1.32 1 0.251 0.09
Agree 57 50.9% 55 49.1% 112
My doctor provided more comprehensive prenatal care following my diagnosis/screenin g results to improve the health outcomes and viability of my baby Disagree 20 74.1% 7 25.9% 27 6.94 1 0.008 0.21
Agree 63 46.3% 73 53.7% 136
My doctor gave me resources about medical problems that people with Down syndrome may have Disagree 62 56.9% 47 43.1% 109 3.77 1 0.052 0.15
Agree 22 40.7% 32 59.3% 54
My doctor talked to me about medical problems that people with Down syndrome may have Disagree 40 58.0% 29 42.0% 69 1.99 1 0.159 0.11
Agree 44 46.8% 50 53.2% 94
Social Guideline
My doctor gave me information about a local Down syndrome support group Disagree 73 63.5% 42 36.5% 115 24.64 1  < 0.001 0.39
Agree 10 20.8% 38 79.2% 48
My doctor gave me information about a national Down syndrome advocacy organization Disagree 69 56.6% 53 43.4% 122 5.60 1 0.018 0.19
Agree 14 35.0% 26 65.0% 40
My doctor gave me accurate, up-to-date, and balanced resources about Down syndrome at the moment of diagnosis in language I could understand Disagree 76 67.3% 37 32.7% 113 39.45 1  < 0.001 0.50
Agree 6 12.8% 41 87.2% 47
My doctor gave me resources about the improved social and life outcomes for people with Down syndrome Disagree 75 60.0% 50 40.0% 125 18.40 1  < 0.001 0.34
Agree 7 19.4% 29 80.6% 36
My doctor talked to me about the improved social and life outcomes for people with Down syndrome Disagree 74 69.8% 32 30.2% 106 41.42 1  < 0.001 0.51
Agree 9 16.4% 46 83.6% 55
My doctor gave me resources about supports and services for people with Down syndrome (like Early Intervention) Disagree 73 57.5% 54 42.5% 127 10.32 1 0.001 0.25
Agree 9 26.5% 25 73.5% 34
My doctor talked to me about supports and services for people with Down syndrome (like Early Intervention) Disagree 73 60.8% 47 39.2% 120 17.64 1  < 0.001 0.33
Agree 9 22.5% 31 77.5% 40
Emotional Guideline
My doctor said"I'm sorry"when telling me my baby had Down syndrome Agree 53 74.6% 18 25.4% 71 32.38 1  < 0.001 0.46
Disagree 23 28.4% 58 71.6% 81
My doctor acted like a diagnosis of Down syndrome was bad news Agree 64 73.6% 23 26.4% 87 39.91 1  < 0.001 0.50
Disagree 16 22.9% 54 77.1% 70

*Statistically significant values are highlighted in gray

Qualitative Data Analyses

When assessing the answers to the survey questions describing the patient diagnosis experiences, two reviewers (a bioethicist and a rhetorician/disability health specialist) performed a sentiment analysis (SA). (See Fig. 1). First, they used a scale of 1–5 to assess patient experiences with each type of medical provider mentioned in each response (Obstetrician, genetic counselor, midwife, geneticist, and maternal–fetal medicine specialist) with a defined rubric based on Pang and Lee’s standards used for software opinion mining and SA (Pang and Lee 2008). The complexity of the language nuance in the responses required the gold standard of expert human interpretation (van Atteveldt et al. 2021). The two primary reviewers determined the coding rubric after creating a proposed scale, reading the first 20 responses, then refining the scale after discussion. After the two reviewers independently assigned sentiment scores for each type of provider mentioned in each response, they met to discuss and resolve any differences in coding.

Fig. 1.

Fig. 1

Sentiment Analysis Methodology Flowchart (Lucid)

Subsequently, the reviewers assigned an overall score for each respondent determined by the general description of the experience and a composite of the scores for each provider (maternal–fetal medicine specialists, obstetricians, genetic counselors, and midwives) using the following composite scoring guide for the overall experience:

  • 1: Negative: Negative scores present for at least one provider. No positive descriptors used or positive score for any provider.
    • o
      Example: “They can mail you a bill but can’t mail you a brochure or anything! Infuriating!”
  • 2: Neutral: Only neutral scores given for all providers for each respondent. No negative descriptors or negative score for any provider.
    • o
      Example: “My OB called me to tell me the ultrasound result and that he was referring me to a pediatric cardiologist.”
  • 3: Mixed: Both positive and negative scores given for providers for each respondent. No example provided because these scores were omitted.

  • 4: Positive: Positive scores present for at least one provider for each respondent. No negative descriptors or negative score for any provider.
    • o
      Example: “My OB gave me wonderful and comprehensive care … She provided me a lot of support.”

The 11 (0.05%) unresolved ratings were sent to a third rater, a developmental disabilities expert, for independent scoring; differences were resolved and final scores determined by consensus between all three raters. Eighteen (10.8%) respondents generally described the experience but did not mention a specific provider. Therefore, the composite score was used as the most inclusive SA score for conducting the statistical analysis. For this analysis, we only considered negative, neutral, and positive composite SA scores, since mixed scores (where patients provided both positive and negative descriptions) could not be directly correlated with the extent to which the recommended practices impacted a positive or negative experience. The study sample thus consisted of 167 out of 242 total participants who 1) indicated they had seen an MFM or OB; 2) provided answers to the 14 OB/MFM questions; and 3) answered the qualitative survey items (“Please describe your diagnosis experience”), which was classified as a positive, neutral, or negative patient diagnosis experience. Finally, we formed two contrasting groups (negative vs non-negative experiences) as we were more concerned about why some patients had negative experiences; the positive and neutral groups were combined, giving us two SA groups: negative and neutral/positive. Moreover, combining the neutral/positive SA scores isolated the definition of neutral/positive to be: no negative verbiage used to describe the experience, and isolated the definition of negative to be: only negative verbiage used to describe the experience. We used this method to control for differences in broader multidisciplinary team approaches because a negative score meant that no positive descriptors were used by a participant to describe any individual providers the entire experience. In contrast, among those who received a neutral or positive score, no negative descriptors were used by a participant to describe an individual provider or the entire experience. Therefore, no providers on the team changed the sentiment of the experience. Moreover, patients in previous studies have indicated that the information included in our survey needs to be provided right away by obstetric care providers upon first learning about a likely diagnosis to improve outcomes (Artal et al. 2025; Levis et al. 2012).

Quantitative data analyses

To assess physician adherence to recommended practices, 14 total recommendations were used, among which two were reverse coded before the analysis (See Table 4). These adherence indicators were dichotomous variables with two categorical choices (0 = Disagree and 1 = Agree). Among these items, the research team grouped together five items about physician adherence to medical recommendations, seven about adherence to social recommendations, and two about adherence to emotional recommendations. For each of these sub-scales, the items were averaged to form a composite variable with higher scores indicating better or more adherence. Kuder-Richardson Formula 20 (KR-20), a measure appropriate for the scales based on dichotomous variables, was used to assess the internal consistency reliability for the three sub-scales (Kuder and Richardson 1937). The reliability coefficients were 0.55, 0.88, and 0.72 for the medical, social and emotional sub-scales, respectively.

Statistical analyses

For Research Question 1, a logistic regression analysis was conducted using the statistical package SPSS 28 (IBM Corp 2021) to examine how the independent variables of adherence to medical, social, and emotional recommendations, evaluated by patients, are related to the dependent variable of patient diagnosis experience. The dependent variable was a dichotomous variable with 0 representing negative experience and 1 representing a neutral/positive experience. Methodologically, the composite independent variables of adherence to medical, social, and emotional recommendations are continuous. However, adherence to emotional recommendations has a limited number and range of values, and caution is warranted when interpreting its coefficient to avoid the issue of extrapolation.

For Research Question 2, a relative weight analysis for logistic regression (RWA) (J. W. Johnson 2000; Tonidandel and LeBreton 2015) was conducted to examine the relative importance of the three independent variables (i.e., adherence to medical, social, and emotional recommendations) in their explanatory power for the dependent variable (i.e., patient diagnosis experience). Confidence intervals and corresponding significance tests for the relative weight of individual independent variables were calculated and performed using bootstrapping with 5,000 replications; also, the ordinary least square R2 statistic was adopted in the logistic relative weight analysis (Petscher et al. 2013). The RWA in this study was performed in R (R Core Team 2024; Tonidandel and LeBreton 2015). The alpha significance level for all the hypothesis tests in this study was set at 0.05.

Results

Based on assessments of diagnosis experiences through sentiment analysis, about 49.1% of the 167 respondents from 41 different states received a neutral or positive score, and about 50.9% received a negative score. Before conducting the logistic regression for Research Question 1, descriptive statistics demonstrated how the recommendations and the composite variables were associated with patient diagnosis experiences. Table 4 displays the frequencies for the 14 recommended practices and the chi-squared test of independence. Only three of 14 adherence indicators, which were focused on medical issues, were not significantly associated with patient diagnosis experiences. The remaining 11 adherence indicators focused on social and emotional factors were significantly associated with patient diagnosis experiences (all p-values ≤ 0.001). A pattern of the relationships emerged from the significant independence tests: patients who found the physicians adhered to all the diagnosis recommendations were more likely to report neutral/positive experience. The effect size of the association, as measured by Cramer’s V, for most of the significant independence tests was moderate or large by according to Cohen’s (1988) commonly used guidelines (i.e., 0.1 = small, 0.3 = moderate, and 0.5 = large).

Table 5 displays the means and standard deviations of the three composite adherence variables (i.e., adherence to medical, social, and emotional recommendations) by the two patient diagnosis experience outcomes (negative vs. neutral/positive) and the independent sample t-test results. The three composite variables were all significantly related to patient diagnosis experiences. Patients reporting neutral/positive diagnosis experiences on average had higher evaluation of their physician’s adherence to the medical, social, and emotional recommendations than their counterparts reporting negative experiences (all p-values < 0.001).

Table 5.

Descriptive statistics and independent t-tests for composite guideline adherence variables (N = 167)

Patient Diagnosis Experience
Variable Negative Neutral/Positive t df p
N M (SD) N M (SD)
Medical 84 0.54 (0.27) 80 0.68 (0.26) −3.45 162  < 0.001
Social 84 0.11 (0.21) 80 0.43 (0.37) −6.76* 123.84  < 0.001
Emotional 81 0.26 (0.37) 80 0.72 (0.40) −7.59 159  < 0.001

*Welch’s t-test to address unequal variances

For Research Question 1, the logistic regression analysis is summarized in Table 6. The Wald chi-squared test statistic provides an inferential test of each logistic regression coefficient, and the odds ratio (OR) coefficient provides information related to the change in the odds of having a neutral/positive experience that would be associated with a one-unit change in each independent variable. Adherence to medical recommendations was not significantly related to patient diagnosis experience (Wald χ2 = 1.32, df = 1, p = 0.25; OR = 2.51).

Table 6.

Logistic regression results for the outcome variable of patient diagnosis experience (N = 167)

Variable Coef S.E Wald df p OR
Medical 0.920 0.800 1.322 1 0.250 2.510
Social 2.874 0.803 12.824 1  <.001 17.712
Emotional 2.431 0.478 25.875 1  <.001 11.368
Constant −2.391 0.557 18.403 1  <.001 0.092

However, adherence to social recommendations was significantly related to patient diagnosis experience (Wald χ2 = 12.82, df = 1, p < 0.001; OR = 17.71); for each increase in 1 unit of adherence to social recommendations, the estimated odds of having a neutral/positive diagnosis experience would increase by a factor of 17.7 if the other two adherence variables are held constant in the model. In the context of this study, the odds of having a neutral/positive diagnosis experience were about 18 times greater for those patients who found their physicians adhered to all seven social recommendations than for those who found their physicians did not adhere to any social recommendations, if controlling for all the other variables in the model.

Similarly, adherence to emotional recommendations was significantly related to patient diagnosis experience (Wald χ2 = 25.88, df = 1, p < 0.001; OR = 11.37); for each increase in 1 unit of adherence to emotional recommendations, the estimated odds of having a neutral/positive diagnosis experience would increase by a factor of 11.4 if the other two adherence variables are held constant in the model. In the context of this study, the odds of having a neutral/positive diagnosis experience were 11.4 times greater for those patients who found their physicians adhered to both emotional recommendations (not saying “I’m sorry” and not conveying the diagnosis as bad news) than for those who found their physicians did not adhere to either emotional guideline, if controlling for all the other variables in the model.

For Research Question 2, a relative weight analysis for logistic regression was conducted. The ordinary least square R2 statistic was adopted in the logistic relative weight analysis as a proxy for the total variance in patient diagnosis experience that was accounted for by the three adherence variables (Petscher et al. 2013). Table 7 displays the raw variance (i.e., relative weight) explained by each adherence variable, the 95% confidence interval for the individual relative weights, and the rescaled relative weights that were obtained by dividing each relative weight by R2. The analysis results indicate that the three adherence variables explained 41% of the variance in patient diagnosis experience (R2 = 0.41). The relative weights of adherence to medical, social, and emotional recommendations were 0.04, 0.17, and 0.20, respectively. In other words, the medical, social, and emotional adherence variables accounted for 4%, 17%, and 20% of the variance in patient diagnosis experience, respectively. All the three adherence variables explained a statistically significant amount of the variance in patient diagnosis experience as the 95% CIs for the relative weights did not contain zero. The rescaled relative weights exhibit the relative importance of the three adherence variables more clearly. Most of the explained variance in patient diagnosis experiences was attributed to adherence to emotional recommendations (48% of R2) and adherence to social recommendations (42% of R2); the rest of the explained variance (10% of R2) was attributed to adherence to medical recommendations.

Table 7.

Summary of logistic regression relative weight analysis

Variable RW CI-L CI-U RS-RW (%)
Medical 0.0401 0.0088 0.0958 9.77%
Social 0.1717 0.0746 0.2674 41.77%
Emotional 0.1992 0.1077 0.3084 48.46%

RW Relative Weight; CI-L Confidence Interval around Relative Weight – Lower Bound; CI-U Confidence Interval around Relative Weight – Upper Bound; RS-RW Rescaled-Relative Weight

Comment

Principal findings

This study contributes to the literature by assessing whether physician adherence to professional recommendations for delivering prenatal screening/diagnosis results impact patient diagnosis experiences, and if so, which subset of these recommendations (medical, social, or emotional) most correlate with positive patient experiences. For our first research question, we found that adherence to both social and emotional recommendations was significantly related to neutral/positive patient diagnosis experiences, with an effect size of moderate to large for the majority of those 11 practices. Moreover, we found that adherence to emotional and social recommendations explained relatively more variance in patient diagnosis experiences than adherence to medical recommendations.

Our findings are consistent with previous literature in demonstrating the high percentage of negative experiences and the importance of psychosocial information and support (May et al. 2020; Meredith et al. 2023; Nelson Goff et al. 2013). However, this is the first study that has found the extent to which physicians follow the emotional and social recommendations can result in strikingly different patient perceptions of their diagnosis experiences as neutral/positive vs. negative.

Clinical implications

Given that over half of patients described their diagnosis experiences as negative due to the absence of social and emotional information and supports, the clinical implications are that obstetricians and gynecologists should recognize that saying “I’m sorry” or assuming that a potential diagnosis of DS is “bad news” can project a value-based judgement about life with DS and negatively influence the patient experience. Clinicians can still convey empathy and understanding for some patients who may feel emotional distress upon learning about a potential DS diagnosis or related comorbidities. To do so effectively, clinicians can follow best practices as outlined in the UK Consensus Guidelines for Communication in Obstetric Ultrasound and our previously published Recommendations to initially deliver the potential DS diagnosis with neutral and unbiased language and then provide emotional support and reflective listening as needed based on patient reactions (Johnson et al. 2020; Meredith et al. 2022). In addition, clinicians need to be sure to provide accurate, balanced, and up-to-date information about the life outcomes for people with DS and talk to their patients, in depth, about the improved social and life outcomes for people with DS that have been developed and achieved in recent years. Systemically, professional medical organizations can offer more explicit guidelines about how to provide social and emotional support and training for clinicians to navigate delicate conversations such as the Brighter Tomorrows training modules (Kleinert et al. 2009). An investment in these strategies could improve the diagnosis experience for patients, improve the emotional health of pregnant patients, and strengthen relationships of trust between providers and patients, particularly for those with intersectional identities (Carroll et al. 2018; Chung et al. 2023).

Research implications

Further research needs to determine if patients learning about other prenatal diagnoses have similar needs and if the provision of information about social determinants of health for people with disabilities at this early stage can potentially improve the health of medically vulnerable children (Kennedy and Wood 2020). Moreover, additional research needs to examine the specific needs of patients who terminate pregnancies following a diagnosis.

Strengths and limitations

This study is the largest study to date of those who received a prenatal diagnosis of Down syndrome and continued pregnancy and is very recent with a statistically rigorous analysis.

Several limitations should be noted within this study (Ijaz et al. 2024; Meredith et al. 2023):

  1. Like most of the previous studies on patient diagnosis experiences, our sample included an over-representation of White respondents. This limitation is especially important given disparities in health care and outcomes for individuals with DS in minority populations, as well as cultural understandings of disability (Chung et al. 2023; Krell et al. 2023).

  2. When our survey participants completed the quantitative questions about what their physician did or did not do, we did not ask them to specify if they were referring to their OB or MFM specialist (for those patients who had both). To minimize this limitation, we did not include the mixed responses in our SA scores, in which multiple providers were rated differently by the same patient.

  3. Participant recall bias can be a factor; however, our respondents’ experiences were relatively recent (2016–2021) and the reception of a possible prenatal diagnosis of DS has been documented as a “flashbulb memory” (May et al. 2020).

  4. Our findings may be positively skewed since advocacy organization participants lived in regions with medical outreach programs; thus, these results might not be generalizable to expectant couples without those supports.

  5. We did not control for any background variable(s) in the analysis and therefore do not know to what extent patient diversity may have impacted our results, nor can we be certain that our results would generalize to a more international study.

Conclusions

Given the profound impact of emotional, social, and informational recommendations on the diagnosis experiences of patients receiving prenatal screening results, OBs can significantly improve patient experiences and support their psychological and emotional needs by providing 1) access to accurate, balanced, and up-to-date information about disabilities and 2) being better trained on disability awareness and delivery of prenatal screening results.

Supplementary Information

Below is the link to the electronic supplementary material.

Acknowledgements

We are grateful to the participation and support of the 12 local Down syndrome organizations and the Down Syndrome Diagnosis Network who assisted with recruitment and evaluating the study.

Author contributions

S.M.: conceptualization, data curation, formal analysis (sentiment analysis), funding acquisition, investigation, methodology, project administration, resources, supervision, visualization, writing-original draft, writing-review and editing H.K.: formal analysis (sentiment analysis), methodology, project administration, writing-original draft, writing-review and editing J.L.: formal analysis (statistics), writing-original draft, writing-review and editing, and visualization S.W.: data curation, formal analysis (sentiment analysis), methodology, writing-review and editing J.D.: formal analysis, writing-review and editing.

Data availability

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.

Declarations

Ethics statement

The study was approved for human subjects on 4/6/2020 research by the University of Kentucky IRB (55360).

Patient consent statement

The study only included participants who were 18 or older, and participants completed IRB-approved online consent forms.

Competing interests

Dr. Harold Kleinert, Jian Li, Sierra Weiss, and Jonathan Drummond have no conflicts of interest to declare. Dr. Stephanie Meredith serves on the advisory board of the National Down Syndrome Congress in a volunteer capacity and the Trisomy Collaborative as a paid consultant and is the parent of an adult with Down syndrome. She has also received remuneration from Down syndrome non-profit organizations and non-profit medical/genetics organizations/programs (National Society of Genetic Counselors, American College of Osteopathic Obstetricians and Gynecologists, American College of Medical Genetics and Genomics, and American Society of Human Genetics) for speaking engagements and associated travel expenses.

Footnotes

Note: “Diagnosis experiences” include both patients receiving diagnostic results and the cell-free DNA screening results. Most parents of children with Down syndrome do not proceed with diagnostic testing, and the vast majority (89%) consider screening the most important stage for receiving information about DS (Meredith et al. 2023).

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  1. American College of Obstetricians and Gynecologists’ Committee on Practice Bulletins—Obstetrics, Committee on Genetics, & Society for Maternal-Fetal Medicine (2020) Screening for fetal chromosomal abnormalities: ACOG practice bulletin, number 226. Obstet Gynecol 136(4):e48–e69. 10.1097/AOG.0000000000004084 [DOI] [PubMed] [Google Scholar]
  2. Artal JM, Randall L, Rubeck S, Allyse M, Michie M, Riggan KA, Meredith S, Skotko BG (2024) Parents of children with Down syndrome reflect on their postnatal diagnoses, 2003–2022. Am J Med Genet A 194(8):e63619. 10.1002/ajmg.a.63619 [DOI] [PubMed] [Google Scholar]
  3. Artal JM, Randall L, Rubeck S, Allyse M, Michie M, Riggan KA, Meredith S, Skotko BG (2025) Prenatal care of parents who continued pregnancies with Down syndrome, 2003–2022. Am J Med Genet Part A, e63981. 10.1002/ajmg.a.63981 [DOI] [PubMed]
  4. Bull MJ, Trotter T, Santoro SL, Christensen C, Grout RW, The Council on Genetics (2022) Health supervision for children and adolescents with Down syndrome. Pediatrics 149(5):e2022057010. 10.1542/peds.2022-057010 [DOI] [PubMed] [Google Scholar]
  5. Carroll C, Carroll C, Goloff N, Pitt MB (2018) When bad news isn’t necessarily bad: recognizing provider bias when sharing unexpected news. Pediatrics 142(1):e20180503. 10.1542/peds.2018-0503 [DOI] [PubMed] [Google Scholar]
  6. Chung J, Krell K, Pless A, Michael C, Torres A, Baker S, Blake JM, Caughman K, Cullen S, Gallagher M, Hoke-Chandler R, Maina J, McLuckie D, O’Neill K, Peña A, Royal D, Slape M, Spinazzi NA, Torres CG, Skotko BG (2023) Healthcare experiences of patients with Down syndrome from primarily Spanish-speaking households. Am J Med Genet A 191(8):2132–2141. 10.1002/ajmg.a.63250 [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Cohen J (1988) Statistical power analysis for the behavioral sciences, 2nd edn. L. Erlbaum Associates [Google Scholar]
  8. Crombag NM, Page-Christiaens GC, Skotko BG, De Graaf G (2020) Receiving the news of Down syndrome in the era of prenatal testing. Am J Med Genet A 182(2):374–385. 10.1002/ajmg.a.61438 [DOI] [PubMed] [Google Scholar]
  9. Driscoll DA, Morgan MA, Schulkin J (2009) Screening for Down syndrome: changing practice of obstetricians. Am J Obstet Gynecol 200(4):459.e1-459.e9. 10.1016/j.ajog.2008.12.027 [DOI] [PubMed] [Google Scholar]
  10. Gregg AR, Skotko BG, Benkendorf JL, Monaghan KG, Bajaj K, Best RG, Klugman S, Watson MS (2016) Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med 18(10):1056–1065. 10.1038/gim.2016.97 [DOI] [PubMed] [Google Scholar]
  11. Hedov G, Wikblad K, Annerén G (2002) First information and support provided to parents of children with Down syndrome in Sweden: clinical goals and parental experiences. Acta Paediatr 91(12):1344–1349. 10.1111/j.1651-2227.2002.tb02832.x [DOI] [PubMed] [Google Scholar]
  12. Hippman C, Inglis A, Austin J (2012) What is a “Balanced” Description? insight from parents of individuals with Down syndrome. J Genet Couns 21(1):35–44. 10.1007/s10897-011-9417-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hui L, Ellis K, Mayen D, Pertile MD, Reimers R, Sun L, Vermeesch J, Vora NL, Chitty LS (2023) Position statement from the international society for prenatal diagnosis on the use of non-invasive prenatal testing for the detection of fetal chromosomal conditions in singleton pregnancies. Prenat Diagn 43(7):814–828. 10.1002/pd.6357 [DOI] [PubMed] [Google Scholar]
  14. IBM Corp. (2021). IBM SPSS statistics for windows, Version 28.0 [Computer software]. IBM Corp
  15. Ijaz MR, Trepanier AM, Kleinert HL, Weiss SM, Meredith SH (2024) Parent‐reported genetic counselor adherence to the NSGC practice resource for communicating a potential prenatal diagnosis: Impact on the Down syndrome diagnosis experience. J Genet Couns, jgc4.1948. 10.1002/jgc4.1948 [DOI] [PubMed]
  16. Johnson JW (2000) A heuristic method for estimating the relative weight of predictor variables in multiple regression. Multivar Behav Res 35(1):1–19. 10.1207/S15327906MBR3501_1 [DOI] [PubMed] [Google Scholar]
  17. Johnson J, Arezina J, Tomlin L, Alt S, Arnold J, Bailey S, Beety H, Bender-Atik R, Bryant L, Coates J, Collinge S, Fishburn J, Fisher J, Fowler J, Glanville T, Hallett J, Harley-Roberts A, Harrison G, Horwood K, … Hardicre NK (2020) UK consensus guidelines for the delivery of unexpected news in obstetric ultrasound: The ASCKS framework. Ultrasound 28(4), 235–245. 10.1177/1742271X20935911
  18. Kennedy J, Wood EG (2020) Disability-based disparities in social determinants of health among working-age adults: evidence from the 2018 national health interview surveys. The Collaborative on Health Reform and Independent Living (CHRIL). https://static1.squarespace.com/static/5abe7e9b5ffd206d61d648ef/t/5f80b97ec617441793f29090/1602271616411/CHRIL+Disparities+Report.pdf. Accessed 27 Dec 2024
  19. Kleinert HL, Lunney CA, Campbell L, Ferguson JE (2009) Improving residents’ understanding of issues, comfort levels, and patient needs regarding screening for and diagnosing Down syndrome. Am J Obstet Gynecol 201(3):328.e1-328.e6. 10.1016/j.ajog.2009.05.051 [DOI] [PubMed] [Google Scholar]
  20. Krell K, Pless A, Michael C, Torres A, Chung J, Baker S, Blake JM, Caughman K, Cullen S, Gallagher M, Hoke-Chandler R, Maina J, McLuckie D, O’Neill K, Peña A, Royal D, Slape M, Spinazzi NA, Torres CG, Skotko BG (2023) Healthcare experiences of patients with Down syndrome who are Black, African American, of African descent, or of mixed race. Am J Med Genet A 191(3):742–752. 10.1002/ajmg.a.63069 [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kuder GF, Richardson MW (1937) The theory of the estimation of test reliability. Psychometrika 2(3):151–160. 10.1007/BF02288391 [Google Scholar]
  22. Levis DM, Harris S, Whitehead N, Moultrie R, Duwe K, Rasmussen SA (2012) Women’s knowledge, attitudes, and beliefs about Down syndrome: a qualitative research study. Am J Med Genet A 158A(6):1355–1362. 10.1002/ajmg.a.35340 [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. May CP, Dein A, Ford J (2020) New insights into the formation and duration of flashbulb memories: evidence from medical diagnosis memories. Appl Cogn Psychol 34(5):1154–1165. 10.1002/acp.3704 [Google Scholar]
  24. Meredith S, Brackett S, Diaz KM, Freeman KG, Huggins E, Khan H, Leach MW, Levitz M, Michie M, Onufer J, Skotko BG, Smith L, Nicole White A, Waller T, Ayers K (2022) Recommendations to improve the patient experience and avoid bias when prenatal screening/testing. Disabil Health J, 101401. 10.1016/j.dhjo.2022.101401 [DOI] [PubMed]
  25. Meredith S, Weiss S, Kleinert HL, Tyrrell CA (2023) The impact of implicit and explicit bias about disabilities on parent experiences and information provided during prenatal screening and testing. Disabil Health J, 101514. 10.1016/j.dhjo.2023.101514 [DOI] [PubMed]
  26. Nelson Goff BS, Springer N, Foote LC, Frantz C, Peak M, Tracy C, Veh T, Bentley GE, Cross KA (2013) Receiving the initial Down syndrome diagnosis: a comparison of prenatal and postnatal parent group experiences. Intellect Dev Disabil 51(6):446–457. 10.1352/1934-9556-51.6.446 [DOI] [PubMed] [Google Scholar]
  27. Pang B, Lee L (2008) Opinion mining and sentiment analysis. Found Trends Inf Retr 2(1–2):1–135. 10.1561/1500000011 [Google Scholar]
  28. Petscher YM, Schatschneider C, Compton DL, Petscher Y (Eds) (2013). Applied quantitative analysis in education and the social sciences (1. publ). Routledge
  29. R Core Team (2024) R: A language and environment for statistical computing. [Computer software]. R Foundation for Statistical Computing
  30. Sheets KB, Best RG, Brasington CK, Will MC (2011a) Balanced information about Down syndrome: what is essential? Am J Med Genet A 155(6):1246–1257. 10.1002/ajmg.a.34018 [DOI] [PubMed] [Google Scholar]
  31. Sheets KB, Crissman BG, Feist CD, Sell SL, Johnson LR, Donahue KC, Masser-Frye D, Brookshire GS, Carre AM, LaGrave D, Brasington CK (2011b) Practice guidelines for communicating a prenatal or postnatal diagnosis of Down syndrome: recommendations of the national society of genetic counselors. J Genet Couns 20(5):432–441. 10.1007/s10897-011-9375-8 [DOI] [PubMed] [Google Scholar]
  32. Skotko BG (2005) Prenatally diagnosed Down syndrome: mothers who continued their pregnancies evaluate their health care providers. Am J Obstet Gynecol 192(3):670–677. 10.1016/j.ajog.2004.11.001 [DOI] [PubMed] [Google Scholar]
  33. Skotko BG, Kishnani PS, Capone GT, for the Down Syndrome Diagnosis Study (2009) Prenatal diagnosis of Down syndrome: How best to deliver the news. Am J Med Genet Part A 149A(11):2361–2367. 10.1002/ajmg.a.33082 [DOI] [PubMed] [Google Scholar]
  34. Tonidandel S, LeBreton JM (2015) RWA web: a free, comprehensive, web-based, and user-friendly tool for relative weight analyses. J Bus Psychol 30(2):207–216. 10.1007/s10869-014-9351-z [Google Scholar]
  35. van Atteveldt W, van der Velden MACG, Boukes M (2021) The validity of sentiment analysis: comparing manual annotation, crowd-coding, dictionary approaches, and machine learning algorithms. Commun Methods Meas 15(2):121–140. 10.1080/19312458.2020.1869198 [Google Scholar]
  36. Williams C, Alderson P, Farsides B (2002) What constitutes ‘balanced information in the practitioners’ portrayals of Down’s syndrome? Midwifery 18(3):230–237. 10.1054/midw.2002.0316 [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.


Articles from Journal of Community Genetics are provided here courtesy of Springer

RESOURCES